Treatment of disfiguring chronic graft versus host disease in a child with topical pimecrolimus

Pediatrics International

Volumn 52, Issue 3, 2010, Pages

  Zangrilli, Arianna ^a   Campione, Elena ^a   Diluvio, Laura ^a   Paternò, Evelin Jasmine ^a   Orlandi, Augusto ^a   Simone, Maria Domenica ^a   Chimenti, Sergio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Chronic cutaneous graft versus host disease (GVHD); Immune modulation therapy; Pimecrolimus

Indexed keywords

ANTIBIOTIC AGENT; CORTISONE; CYCLOSPORIN A; HEMOSIDERIN; PIMECROLIMUS;

ABSENCE OF SIDE EFFECTS; ANTIBIOTIC THERAPY; ARTICLE; AUTOIMMUNE THYROIDITIS; BETA THALASSEMIA; BONE MARROW TRANSPLANTATION; BORDERLINE HYPERTENSION; BOY; BRONCHIOLITIS; CASE REPORT; CHEMOTHERAPY; CHEST INFECTION; CHILD; CHRONIC CUTANEOUS GRAFT VERSUS HOST DISEASE; CHRONIC GRAFT VERSUS HOST DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; DRUG TOLERABILITY; DYSTROPHY; ENDOCRINE DISEASE; ERYTHEMA; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; GLAUCOMA; GROWTH HORMONE DEFICIENCY; HUMAN; HYPERKERATOSIS; HYPERPIGMENTATION; HYPOTHYROIDISM; IRAN; LOW DRUG DOSE; MALE; MYCOPLASMA; MYCOPLASMOSIS; NAIL DYSTROPHY; OBESITY; ORAL MUCOSAL DISEASE; OSTEOPOROSIS; PALATE; PRIORITY JOURNAL; PRURITUS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PUNCH BIOPSY; PUVA; RADIATION EXPOSURE; SCHOOL CHILD; SEBORRHEA; SKIN ATROPHY; SKIN BIOPSY; SKIN DEFECT; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC THERAPY; TONGUE; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; BETA-THALASSEMIA; BONE MARROW TRANSPLANTATION; CHEMOTHERAPY, ADJUVANT; CHILD; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DERMATITIS, SEBORRHEIC; DERMATOLOGIC AGENTS; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; MALE; RADIOTHERAPY, ADJUVANT; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TREATMENT OUTCOME;

EID: 77953628435     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03078.x     Document Type: Article

References (11)

1. Hausermann P, Walter BR, Halter J et al. Cutaneous graft-versus-host disease: A guide for the dermatologist. Dermatology 2008 216 : 287 304.
2. Schmook T, Kraft J, Benninghoff B et al. Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus. Bone Marrow Transplant. 2005 36 : 87 8.
3. Ziemer M, Gruhn B, Thiele JJ, Elsner P. Treatment of extensive chronic cutaneous graft-versus-host disease in an infant with topical pimecrolimus. J. Am. Acad. Dermatol. 2004 50 : 946 948.
4. Epstein JB, Gorsky M, Epstein MS, Nantel S. Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: A series of cases. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2001 91 : 56 61.
5. Fricain JC, Sibaud V, Swetyenga N, Tabrizi R, Campana F, Taïeb A. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease. Br. J. Dermatol. 2007 156 : 588 590.
6. Gupta AK, Chow M. Pimecrolimus: A review. JEADV 2003 17 : 493 503.
7. Tzellos TG, Kouvelas D. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: An evidence-based evaluation. Eur. J. Clin. Pharmacol. 2007.
8. Lee HH, Zuberbier T, Worm M. Treatment of atopic dermatitis with pimecrolimus - impact on quality of life. Ther. Clin. Risk Manag. 2007 3 : 1021 1026.
9. Ständer S, Schürmeyer-Horst F, Luger TA, Weisshaar E. Treatment of pruritic diseases with topical calcineurin inhibitors. Ther. Clin. Risk Manag. 2006 2 : 213 218.
10. Karabulut AA, Izol Serel B, Eksioglu HM. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea. J. Eur. Acad. Dermatol. Venereol. 2008 22 : 729 734.
11. Bilaç DB, Ermertcan AT, Sahin MT, Oztürkcan S. Two therapeutic challenges: Facial vitiligo successfully treated with 1% pimecrolimus cream and 0.005% calcipotriol cream. J. Eur. Acad. Dermatol. Venereol. 2009 23 : 72 3.